Low Pressure Pneumoperitoneum Using AirSeal® for Reduction in Postoperative Shoulder Pain Following Robot Assisted Hiatal Hernia Repair
Launched by RIVERSIDE UNIVERSITY HEALTH SYSTEM MEDICAL CENTER · Dec 11, 2024
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at ways to reduce shoulder pain that some people experience after having robot-assisted surgery to repair a hiatal hernia, which is a type of hernia that occurs when part of the stomach pushes through the diaphragm. The researchers want to see if using lower pressure to fill the abdomen with carbon dioxide during the surgery can help lessen this pain. Participants will receive standard care for their surgery, but they will also keep track of their pain levels afterward to help the researchers understand the results better.
To take part in this trial, you need to be between 65 and 74 years old and planning to have elective robot-assisted hiatal hernia repair surgery. Unfortunately, if you are under 18, have certain medical conditions, or if you are pregnant, you won't be eligible. If you join the trial, you will have regular follow-up appointments after the surgery just like everyone else, and your experience will help improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients undergoing elective robot assisted hiatal hernia repair
- Exclusion Criteria:
- • patients less than 18 years of age
- • conversion to open surgery
- • BMI \> 40
- • history of abdominoplasty
- • history of chronic pain and/or opioid dependence
- • history of COPD and/or supplemental oxygen use
- • pregnant patients
- • incarcerated patients
- • patient refusal
About Riverside University Health System Medical Center
Riverside University Health System Medical Center (RUHS) is a leading healthcare institution committed to advancing medical research and improving patient outcomes through innovative clinical trials. As a comprehensive medical facility, RUHS integrates cutting-edge technology and a multidisciplinary approach to deliver high-quality care while actively engaging in research initiatives across various therapeutic areas. The center is dedicated to fostering collaborations with academic institutions and industry partners, ensuring that trials are conducted with the highest ethical standards and scientific rigor. Through its robust clinical trial program, RUHS aims to contribute to the development of new therapies and enhance the understanding of complex medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Moreno Valley, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported